Diversity, Equity, and Inclusion in Clinical Trials.
Publication Title
Surgical oncology clinics of North America
Document Type
Article
Publication Date
1-1-2023
Keywords
washington; swedish; swedish cancer; diversity
Abstract
Minority groups are vastly underrepresented in clinical trial participants and leadership. Because these studies provide innovative and revolutionary treatment options to patients with cancer and have the potential to extend survival, it is imperative that public and private stakeholders, as well as hospital and clinical trial leadership, prioritize equity and inclusion of diverse populations in clinical trial development and recruitment strategies. Achieving equity in clinical trials could be an important step in reducing the overall cancer burden and mortality disparities in vulnerable populations.
Area of Special Interest
Women & Children
Area of Special Interest
Cancer
Specialty/Research Institute
Population Health
Specialty/Research Institute
Oncology
DOI
10.1016/j.soc.2022.08.005
